Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025

Core Insights - Adaptimmune Therapeutics plc is set to report its financial results and business updates for Q1 2025 on May 13, 2025, before US markets open [1] - A live webcast will follow the announcement at 8:00 a.m. EDT on the same day [1][2] Company Overview - Adaptimmune is a clinical-stage biopharmaceutical company focused on developing cell therapies aimed at treating solid tumor cancers [3] - The company utilizes a unique engineered T-cell receptor (TCR) platform to create T-cells that target and destroy various solid tumor types [3]